EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 17.30% over 3 years. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
National Healthcare Properties, Inc. (NHP) (NHP)
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 3 comparable quarters.
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $26.76M.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T21:37:48.132Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $78.14M | $81.56M | +$3.43M | +4.38% |
| 2023 | $50.52M | $78.14M | +$27.61M | +54.65% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $26.76M | -4.1% | +105.5% |
| Q1 FY2026 | 2026-03-31 | $27.90M | +144.6% | -28.6% |
| Q4 FY2025 | 2025-12-31 | $11.41M | -44.1% | -41.9% |
| Q3 FY2025 | 2025-09-30 | $20.40M | +56.7% | N/A |
| Q2 FY2025 | 2025-06-30 | $13.02M | -66.7% | N/A |
| Q1 FY2025 | 2025-03-31 | $39.06M | +99.0% | N/A |
| Q4 FY2024 | 2024-12-31 | $19.63M | N/A | N/A |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
